Hepatitis B virus-associated glomerular nephritis in East Asia: Progress and challenges

European Journal of Internal Medicine

Volumn 22, Issue 2, 2011, Pages 161-166

  Xu, Gaosi ^a,b   Huang, Tianlun ^a  

^a NANCHANG UNIVERSITY   (China)

^b JIANGXI MEDICAL COLLEGE   (China)

Author keywords

East Asia; End stage renal disease; HBV associated glomerular nephritis

Indexed keywords

ADEFOVIR DIPIVOXIL; CORTICOSTEROID; ENTECAVIR; INTERFERON; LAMIVUDINE; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ASIA; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION; NATURAL KILLER CELL; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PROGNOSIS; REMISSION; REVIEW; VIREMIA; VIRUS LOAD;

EID: 79952696966     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.11.005     Document Type: Short Survey

References (64)

1. Hepatitis B vaccination coverage among adults - United States 2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2006;55:509-11.
2. Katzenstein PJ, Shiraishi T. Beyond Japan: the dynamics of East Asian regionalism. Ithaca: Cornell University Press; 2006. p. 1-33.
3. Cacoub P, Saadoun D, Bourliere M, Khiri H, Martineau A, Benhamou Y, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005;43:764-70. (Pubitemid 41417733)
4. Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971;2:234-7.
5. Knieser MR, Jenis EH, Lowenthal DT, Bancroft WH, Burns W, Shalhoub R. Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol 1974;97:193-200.
6. Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974;2:477-82.
7. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Eng J Med 1979;300:814-9.
8. Ito H, Hattori S, Matusda I, Amamiya S, Hajikano H, Yoshizawa H, et al. Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli. Lab Investig 1981;44:214-20.
9. Furuse A, Hattori S, Terashima T, Karashima S, Matsuda I. Circulating immune complex in glomerulonephropathy associated with hepatitis B virus infection. Nephron 1982;31:212-8. (Pubitemid 12099248)
10. Hirose H, Udo K, Kojima M, Takahashi Y, Miyakawa Y, Miyamoto K, et al. Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab′) 2 fragments of monoclonal antibody. Kidney Int 1984;26:338-41. (Pubitemid 14021706)
11. Takeda S, Kida H, Katagiri M, Yokoyama H, Abe T, Hattori N. Characteristics of glomerular lesions in hepatitis B virus infection. Am J Kidney Dis 1988;11:57-62. (Pubitemid 18041908)
12. Thyagarajan SP, Thirunalasundari T, Subramanian S, Panchanadam M, Nammalwar BR, Prabha V, Vijayakumar, Jayaraman M. Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies. J Med Microbiol 1989;29:243-9. (Pubitemid 19203743)
13. Zhou WZ, Zhang WL, Geng L. Glomerulonephropathy associated with hepatitis B virus (HBV) infection. Zhonghua Nei Ke Za Zhi 1990;29:530-3.
14. Zhang Y, Fang L, Ma X. Hepatitis B virus infection and pathogenesis of glomerulonephritis. Zhonghua Bing Li Xue Za Zhi 1995;24:341-4.
15. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663-76. (Pubitemid 20056838)
16. Magil A. IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Hum Pathol 1988;19:615.
17. Lin CY, Lin CC, Chang GJ, King CC. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy. Nephron 1997;76:176-85.
18. Haria M, Benfield P. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in management of viral hepatitis. Drugs 1995;50:873-96.
19. Phillips TM. Interferon-alpha induces renal dysfunction and injury. Curr Opin Nephrol Hypertens 1996;5:380-3. (Pubitemid 26249010)
20. Amemiya S, Ito H, Kato K, Sakaguchi H, Hasegawa O, Hajikano H. A case of membranous proliferative glomerulonephritis type III (Burkholder) with the deposition of both HBeAg and HBsAg. Int J Pediatr Nephrol 1983;4:267-73. (Pubitemid 14158387)
21. Wang NS, Wu ZL, Zhang YE, Liao LT. Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy. World J Gastroenterol 2005;11:712-6.
22. Wang NS, Wu ZL, Zhang YE, Guo MY, Liao LT. Role of hepatitis B virus infection in pathogenesis of IgA nephropathy. World J Gastroenterol 2003;9:2004-8.
23. Endo Y, Kanbayashi H. Etiology of IgA nephropathy syndrome. Pathol Int 1994;44:1-13. (Pubitemid 24072128)
24. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004;24:197-217. (Pubitemid 38685990)
25. Galla JH. IgA nephropathy. Kidney Int 1995;47:377-87.
26. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J. The clinicopathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 1987;63:323-33.
27. Zhang YE, Guo MY, Ying YY. Further study on the immunopathology of hepatitis B virus associated glomerulonephritis. Zhonghua Nei Ke Za Zhi 1990;29:526-9.
28. Yan HP, Lang ZW, Huang DZ. Preparation of digoxigenin labelled probe and detection of HBV DNA in liver and extrahepatic tissue with in situ hybridization. Zhonghua Nei Ke Za Zhi 1994;33:168-71.
29. Lai KN, Ho RT, Tam JS, Lai FM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis. Kidney Int 1996;50:1965-77. (Pubitemid 26417540)
30. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285-93.
31. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-4. (Pubitemid 32786652)
32. Kusakabe A, Tanaka Y, Kurbanov F, Goto K, Tajiri H, Murakami J, et al. Virological features of hepatitis B virus-associated nephropathy in Japan. J Med Virol 2007;79:1305-11. (Pubitemid 47106266)
33. Zhu H, Lu HZ, Zhou JH, Wu HS, Fang F. Mutation of hepatitis B virus S gene in children with hepatitis B virus-associated glomerulonephritis. Zhonghua Er Ke Za Zhi 2008;46:378-81.
34. Kim SE, Park YH, Chung WY. Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy. Pediatr Nephrol 2006;21:1097-103. (Pubitemid 44083881)
35. Bhimma R, Hammond MG, Coovadia HM, Adhikari M, Connolly CA. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int 2002;61:1510-5. (Pubitemid 34304513)
36. Park MH, Song EY, Ahn C, Oh KH, Yang J, Kang SJ, et al. Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans. Tissue Antigens 2003;62:505-11. (Pubitemid 37475998)
37. Vaughan RW, Zurowska A, Moszkowska G, Kondeatis E, Clark AG. HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy. Tissue Antigens 1998;52:130-4. (Pubitemid 28395820)
38. Xu H, Sun L, Zhou LJ, Fang LJ, Sheng FY, Guo YQ. The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis. Pediatr Nephrol 2003;18:1216-9. (Pubitemid 37527093)
39. Lin CY. Hepatitis B virus-associated membranous nephropathy: clinical features, immunological profiles and outcome. Nephron 1990;55:37-44.
40. Panomsak S, Lewsuwan S, Eiam-Ong S, Kanjanabuch T. Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. J Med Assoc Thai 2006;89:S151-6.
41. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211. (Pubitemid 38456630)
42. Wong DK, Cheung AM, O?Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312-23. (Pubitemid 23319890)
43. Di Bisceglie AM. Long-term outcome of interferon-alpha therapy for chronic hepatitis B. J Hepatol 1995;22:S65-7.
44. Wong SN, Yu EC, Lok AS, Chan KW, Lau YL. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 1992;6:417-20.
45. Chung DR, Yang WS, Kim SB, Yu E, Chung YH, Lee Y, et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997;17:112-7. (Pubitemid 27141900)
46. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005;68:1750-8. (Pubitemid 43169919)
47. Lee CM, Ong GY, Lu SN, Wang JH, Liao CA, Tung HD, et al. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. J Hepatol 2002;37:669-74.
48. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998;27:1670-7. (Pubitemid 28264693)
49. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521-31.
50. Chang TT, Lai CL, Chien RN, Guan R, Lim SG, Lee CM, et al. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 2004;19:1276-82. (Pubitemid 39481762)
51. Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 2000;32:129-34. (Pubitemid 30432377)
52. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-7. (Pubitemid 19284256)
53. Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 2010;16:770-7.
54. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8:11-4. (Pubitemid 24042358)
55. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-63.
56. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997;99:351-3.
57. Noto H, Terao T, Ryou S, Hirose Y, Yoshida T, Ookubo H, et al. Combined passive and active immunoprophylaxis for preventing prenatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. J Gastroenterol Hepatol 2003;18:943-9.
58. Yotsuyanagi H, Okuse C, Yasuda K, Orito E, Nishiguchi S, Toyoda J, et al. Distinct geographic distribution of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol 2005;77:39-46. (Pubitemid 41076474)
59. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993;67:5402-10. (Pubitemid 23241374)
60. Sung JL. Hepatitis B virus eradication strategy for Asia. Asian Reg Study Group Vaccine 1990;8:S95-9.
61. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002;17:457-62.
62. Juon HS, Choi KS, Park EC, Kwak MS, Lee S. Hepatitis B vaccinations among Koreans: results from 2005 Korea National Cancer Screening Survey. BMC Infect Dis 2009;9:185.
63. Tserenpuntsag B, Nelson K, Lamjav O, Triner W, Smith P, Kacica M, et al. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors. Transfusion 2010;50:92-9.
64. Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagvasuren T, Wiersma S, et al. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey. Pediatr Int 2007;49:368-74. (Pubitemid 46802289)